2005 © Oxford University Press
Reproductive Issues for Women With BRCA Mutations
Affiliations of authors: The Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas (LCF); Breast Care Center, Baylor College of Medicine and The Methodist Hospital, Houston, Texas (LCF, RMK)
Correspondence to: Lois C. Friedman, PhD, Baylor College of Medicine, The Menninger Department of Psychiatry and Behavioral Sciences, One Baylor Plaza, Houston, TX 77030 (e-mail: loisf{at}bcm.tmc.edu).
Women carrying BRCA1 and BRCA2 mutations face difficult and confusing reproductive decisions that fall into three categories: issues relating to risk-reducing surgeries, issues relating to use of oral contraceptives/tubal ligation, and issues relating to pregnancy and breastfeeding. Risk-reducing surgeries may confer survival benefits, but they also affect quality of life. Oral contraceptives potentially protect mutation carriers against ovarian cancer but increase the risk of early-onset breast cancer, and evidence for the efficacy of tubal ligation in reducing ovarian cancer risk in BRCA mutation carriers is contradictory. Women with BRCA mutations may increase their risk of breast cancer by becoming pregnant before age 40 years, but breastfeeding may decrease risk of breast cancer in women with BRCA mutations, regardless of age. BRCA mutation carriers desiring to become pregnant must deal with a variety of psychosocial issues, some with significant ethical implications, with minimal guidance from research.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Pasanisi, G. Hedelin, J. Berrino, J. Chang-Claude, S. Hermann, M. Steel, N. Haites, J. Hart, R. Peled, L. Gafa, et al. Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2107 - 2113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lee, H. Ma, R. McKean-Cowdin, D. Van Den Berg, L. Bernstein, B. E. Henderson, and G. Ursin Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3170 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Blank, P.-Y. Wong, R. Lakshmanaswamy, R. Guzman, and S. Nandi Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats PNAS, March 4, 2008; 105(9): 3527 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Y. Karlan and M. McIntosh The Quest for Ovarian Cancer's Holy Grail: Can CA-125 Still Be the Chalice of Early Detection? J. Clin. Oncol., April 10, 2007; 25(11): 1303 - 1304. [Full Text] [PDF]
|
|